Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Armstrong

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Endocrine Connections|November 19, 2017
Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumoursLogan Mills, Panagiotis Drymousis, Yogesh Vashist, et al.
Annals of Surgical Oncology|March 10, 2024
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine TumorsStefano Partelli, Francesca Fermi, Giuseppe K Fusai, et al.
Surgery|December 28, 2020
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative studyGiuseppe K Fusai, Domenico Tamburrino, Stefano Partelli, et al.
The Lancet. Gastroenterology & Hepatology|December 15, 2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trialPaula Ghaneh, Daniel Palmer, Silvia Cicconi, et al.
Frontiers in Medicine|January 11, 2021
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational StudyStefano Partelli, John K Ramage, Sara Massironi, et al.
The British Journal of Surgery|August 20, 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trialStefano Partelli, Sara Massironi, Alessandro Zerbi, et al.
Annals of Surgery|December 15, 2017
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 5, 2023
Sub-classification of laparoscopic left hepatectomy based on hierarchic interaction of tumor location and size with perioperative outcomesAndrea Ruzzenente, Bernardo Dalla Valle, Edoardo Poletto, et al.
Annals of Surgical Oncology|July 28, 2023
Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter StudyYutaro Kato, Atsushi Sugioka, Masayuki Kojima, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Endocrine Connections|November 19, 2017
Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumoursLogan Mills, Panagiotis Drymousis, Yogesh Vashist, et al.
Annals of Surgical Oncology|March 10, 2024
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine TumorsStefano Partelli, Francesca Fermi, Giuseppe K Fusai, et al.
Surgery|December 28, 2020
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative studyGiuseppe K Fusai, Domenico Tamburrino, Stefano Partelli, et al.
The Lancet. Gastroenterology & Hepatology|December 15, 2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trialPaula Ghaneh, Daniel Palmer, Silvia Cicconi, et al.
Frontiers in Medicine|January 11, 2021
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational StudyStefano Partelli, John K Ramage, Sara Massironi, et al.
The British Journal of Surgery|August 20, 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trialStefano Partelli, Sara Massironi, Alessandro Zerbi, et al.
Annals of Surgery|December 15, 2017
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS): Design and International External ValidationTimothy H Mungroop, L Bengt van Rijssen, David van Klaveren, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 5, 2023
Sub-classification of laparoscopic left hepatectomy based on hierarchic interaction of tumor location and size with perioperative outcomesAndrea Ruzzenente, Bernardo Dalla Valle, Edoardo Poletto, et al.
Annals of Surgical Oncology|July 28, 2023
Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter StudyYutaro Kato, Atsushi Sugioka, Masayuki Kojima, et al.
Pageof 8